|
|
|
|
Vol. 18, Issue 1, 166-175, January 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

*Département de Biochimie, Université de Lausanne, 1066 Epalinges, Switzerland; and
Max-Planck-Institut für Entwicklungsbiologie, 72076 Tübingen, Germany
Submitted August 2, 2006;
Revised October 10, 2006;
Accepted October 20, 2006
Monitoring Editor: Howard Riezman
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Macroautophagy in yeast is defined as the uptake of cytosolic contents by fusion of double-layered vesicles (autophagosomes) with vacuoles (Baba et al., 1994
). Autophagosomes originate from a preautophagosomal structure (PAS) in the vicinity of the vacuole and, during their formation, enwrap portions of cytosol. Fusion of the outer autophagosomal layer with the vacuolar membrane liberates autophagic bodies (single-layered intravacuolar vesicles) into the vacuolar lumen for degradation (Takeshige et al., 1992
). Relevant actors of macroautophagy (Atg proteins; Klionsky et al., 2003
) have been identified, mainly by genetic screens (Tsukada and Ohsumi, 1993
; Thumm et al., 1994
; Harding et al., 1995
, 1996
; Titorenko et al., 1995
) and have been studied intensively over the last decade.
Little is known about microautophagy, a process consisting of a direct invagination of the vacuolar boundary membrane and budding of autophagic bodies into the vacuolar lumen (Muller et al., 2000
; Sattler and Mayer, 2000
; Kunz et al., 2004
). Microautophagy of soluble cytosolic components is topologically equivalent to invaginations occurring during multivesicular body (MVB) formation at the endosome, piecemeal microautophagy of the nucleus (PMN) (Roberts et al., 2003
) into the yeast vacuole and micropexophagy in methylotrophic yeasts (Veenhuis et al., 1983
; Tuttle et al., 1993
; Tuttle and Dunn, 1995
; Sakai et al., 1998
; Mukaiyama et al., 2002
, 2004
). Although microautophagy of soluble components, like macroautophagy, is induced by nitrogen starvation and rapamycin (a pharmacological agent inhibiting Tor kinase signaling) and although pexophagic vacuole invagination depends on Atg proteins (Hutchins et al., 1999
; Kim et al., 1999
; Yuan et al., 1999
; Stromhaug et al., 2001
), there is no evidence that Atg proteins are directly involved in either PMN (Roberts et al., 2003
) or microautophagic uptake. Macroautophagy seems to be a prerequisite for microautophagy to occur, however (Sattler and Mayer, 2000
). Microautophagy is controlled by the TOR and EGO (composed of proteins Ego1p, Gtr2p, and Ego3p) signaling complexes (Dubouloz et al., 2005
). It leads to direct uptake and degradation of the vacuolar boundary membrane. Hence the process could compensate the enormous influx of membrane caused by macroautophagy. Based on this evidence, microautophagy appears to be required for the transition from the rapamycin-induced growth arrest to logarithmic growth (Dubouloz et al., 2005
) and for maintenance of organellar size and membrane composition rather than for cell survival under nutrient restriction.
Autophagic tubes (microautophagic vacuole invaginations) show dramatically reduced density of transmembrane particles toward their tips, i.e., toward the site where autophagic bodies pinch off into the vacuolar lumen. Microautophagic vesicles share this exceptional ultrastructural feature with nascent autophagosomes (Muller et al., 2000
). Also nascent autophagosomes are virtually free of intramembraneous particles, suggesting that membrane removal by microautophagy might compensate macroautophagic membrane influx both in terms of quantity and quality. Microautophagic vacuole invagination could be reconstituted in a cell-free system composed of purified vacuoles and cytosolic extracts (Muller et al., 2000
; Sattler and Mayer, 2000
). Using a pharmacological approach, the in vitro uptake reaction could be dissected into different kinetic stages (Kunz et al., 2004
). According to their ability to block the reaction at different kinetic stages, these inhibitors have been defined as early acting class A inhibitors (nystatin, GTP
S, aristolochic acid) and late acting class B inhibitors (W-7, valinomycin/FCCP, K252a, and rapamycin). A putative W-7 target, calmodulin (Cmd1p), acts late during invagination in a calcium-independent way (Uttenweiler et al., 2005
).
In this study we have identified the vacuolar transporter chaperone (VTC) complex as a bona fide Cmd1p target in microautophagy. The VTC complex is enriched at the vacuolar membrane, but also localizes to other cellular compartments (Cohen et al., 1999
; Ogawa et al., 2000
; Muller et al., 2003
). All Vtc proteins contain three C-terminal transmembrane helices. In contrast to Vtc1p, which is small and almost completely embedded in the membrane, Vtc2p, Vtc3p, and Vtc4p possess a large hydrophilic N-terminal domain that faces the cytosol (Muller et al., 2003
). Vtc proteins have been implicated in several aspects of membrane transport and vesicular traffic (Cohen et al., 1999
; Murray and Johnson, 2000
, 2001
; Nelson et al., 2000
; Muller et al., 2002
, 2003
). Here, we have used a combination of microscopic and biochemical approaches to test the role of the VTC complex during microautophagy.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-Chymotrypsin (Sigma, St. Louis, MO), calmodulin sepharose 4B (Amersham Biosciences, Piscataway, NJ), protein A agarose (Roche, Indianapolis, IN), monoclonal mouse anti-His6-antibody (Qiagen, Chatsworth, CA), Ophiobolin A (Sigma), rapamycin (Alexis, Gruenberg, Germany). Drugs were suspended as 5100x stock solution in PS buffer (200 mM sorbitol, 10 mM PIPES/KOH, pH 6.8; W-7, EGTA) or DMSO (ophiobolin A, rapamycin, chymotrypsin substrate I) and stored at 20°C.
Yeast Strains
Strain BY4727 (wild type) and corresponding knockout strains OMY20 (
vtc1), OMY21 (
vtc2), and OMY22 (
vtc3) have been described previously (Muller et al., 2003
). Wild-type VTC4 and the corresponding
vtc4 strain were derived from diploid strain BY262 by sporulation: they are the haploid parental strains that had been used for generating
pep4 strains SBY86 and SBY83 as described before (Muller et al., 2002
). Strains Y10000
[GenBank]
(BY4742, wild type), Y10212
[GenBank]
(
vtc1), Y17273
[GenBank]
(
vtc2), Y12809
[GenBank]
(
vtc3), Y16780
[GenBank]
(
vtc4), Y15382
[GenBank]
(
atg3), Y13104
[GenBank]
(
atg8), Y15078
[GenBank]
(
ego1), Y14793
[GenBank]
(
gtr2), and Y13214
[GenBank]
(
ego3) were purchased from Euroscarf (Frankfurt, Germany). Strain K91-1A was kindly provided by Y. Kaneko. Strains DBY5734 (CMD1 wild type), DBY5706 (cmd1-226), DBY5708 (cmd1-228), DBY5713 (cmd1-233), DBY5719 (cmd1-239; Ohya and Botstein, 1994
), and CRY1 (CMD1 wild type), IGY149 (cmd1-6), IGY148 (cmd1-5; Geiser et al., 1991
) also have been described before. GFP-Pho8p was expressed in wild-type strain DBY5734.
Yeast cells were cultured, and cytosol from strains K91-1A was prepared as described previously (Sattler and Mayer, 2000
).
Vacuole preparation was performed as described previously (Sattler and Mayer, 2000
), but by using yeast lytic enzyme (from Arthrobacter luteus, ICN catalogue number 360944, final concentration: 3.27 mg/ml) or
-1,3-glucanase from Oerskovia xanthineolytica (Shen et al., 1991
; Nichols et al., 1997
; expressed in Escherichia. coli strain RSB 805, final concentration 0.67 mg/ml) instead of oxalyticase. For storage of vacuoles, glycerol (10% wt/vol from a 50% stock) was added to a fresh vacuole suspension. The suspension was frozen as little nuggets in liquid nitrogen and stored at 80°C (Kunz et al., 2004
).
In Vitro Microautophagy Assay
A standard reaction had a volume of 45 µl and was composed of: vacuoles (0.2 mg/ml, either freshly prepared or thawed from a 80°C stock), 6.8 mg/ml (K91-1A-cells) cytosol from starved cells, 105 mM KCl, 7 mM MgCl2, 2.2 mM ATP, 88 mM disodium creatine phosphate, 175 U/ml (0.463 µg/ml) creatine kinase, 17 µg/ml luciferase, 100 µM DTT, 0.1 mM pefabloc SC, 0.5 mM o-phenanthrolin, 0.5 µg/ml pepstatin A, 200 mM sorbitol, 10 mM PIPES/KOH, pH 6.8. This mixture was incubated for 1 h at 27°C. For measuring luciferase uptake the samples were chilled on ice, diluted with 300 µl 150 mM KCl in PS buffer, and centrifuged (6500 x g, 3 min, 2°C, fixed angle table top centrifuge). The pellet was washed once more with 150 mM KCl in PS buffer and resuspended in 55 µl 150 mM KCl in PS buffer. Proteinase K was added (0.3 mg/ml from 18x stock) and incubated on ice for 23 min. Digestion was stopped by adding 55 µl 1 mM phenylmethylsulfonylfluoride (PMSF)/150 mM KCl in PS buffer. Luciferase activity was determined using an assay kit according to the manufacturer's instruction (Berthold Detection Systems, Pforzheim, Germany): 25 µl of sample was mixed with 25 µl of lysis buffer, and 50 µl of substrate mix was added directly before counting light emission in a microplate luminometer (LB 96 V, Berthold Technologies, Bad Wildbad, Germany). Alkaline phosphatase activity was determined in a 25-µl aliquot as described previously to serve as an internal reference for the quantity of pelleted vacuoles. Uptake activity was calculated as the quotient of luciferase activity over alkaline phosphatase activity (counts per second/OD405 per min) and normalized to an uninhibited standard reaction (60 min, 27°C), which was set to 100%. In some mutant strains the level of mature alkaline phosphatase was different (checked by Western blot or alkaline phosphatase assay; data not shown). When comparing such yeast strains, uptake activity was hence not referred to alkaline phosphatase activity but to the protein content of the vacuoles.
Thin-Section Electron Microscopy
Yeast cells were cryoimmobilized by high-pressure freezing as described previously (Hohenberg et al., 1994
). In short, living specimen were sucked into cellulose microcapillaries of 200-µm diameter and 2-mm-long capillary tube segments were transferred to aluminum platelets of 200 µm depth containing 1-hexadecene. The platelets were sandwiched with platelets without any cavity and then frozen with a high-pressure freezer (Bal-Tec HPM 010, Balzers, Liechtenstein). Extraneous hexadecene was removed from the frozen capillary tubes under liquid nitrogen. The frozen capillaries were transferred to 2-ml microtubes with screw caps (Sarstedt no. 72.694) containing the substitution medium precooled to 90°C. Samples for ultrastructural studies were kept in a freeze-substitution unit (Balzers FSU 010, Bal-Tec) in 2% osmium tetroxide in anhydrous acetone at 90°C for 32 h, warmed up to 60°C within 3 h, kept at 60°C for 4 h, warmed up to 40°C within 2 h, and kept there for 4 h. After washing with acetone, the samples were transferred into an acetone-Epon mixture at 40°C, infiltrated at room temperature (RT) in Epon and polymerized at 60°C for 48 h. Samples for immuno/affinity labeling were processed in 0.5% acrolein (WT Vtc4 and
vtc4) or uranyl acetate (WT Vtc3 and
vtc3) in anhydrous ethanol using the same temperature/time schedule for freeze-substitution. After washing with ethanol, the samples were transferred into an ethanol-Lowicryl K11M mixture, infiltrated with the polar methacrylate resin Lowicryl K11M (Polysciences, Eppelheim, Germany), and polymerized by UV irradition at 40°C for 48 h. Immunolabeling was done as described previously (Tommassen et al., 1985
; van Bergen en Henegouwen and Leunissen, 1986
) using affinity-purified antibodies to Vtc3p (N-terminal SPX domain) or to Vtc4p. Anti-Vtc3p (rabbit, 0.5 µg/ml in 0.1% acetylated BSA) and anti-Vtc4p (goat, 3.2 µg/ml in 0.2% gelatin and 0.5% BSA in PBS) were detected via protein A labeled with 15-nm gold particles (the signal for anti-Vtc4p was enhanced with an anti-goat antibody in between). Ultrathin sections, stained with uranyl acetate, were viewed in a Philips CM10 electron microscope at 60 kV.
N-Terminal Tagging of Vtc Proteins with GFP
The genes coding for Vtc1p-Vtc4p were genomically tagged by means of a PCR-based method using the plasmid pYM-N9 (Euroscarf) as described before (Janke et al., 2004
). The tagged proteins were expressed at their genomic locus under control of an integrated ADH promotor in the wild-type yeast strain BY4742 (Euroscarf).
Protein Expression
His6-GST-tagged Vtc domains were expressed in E. coli BL21 in LB medium containing 25 µg/ml kanamycin. Expression was induced at OD600 = 0.5 with 0.5 mM IPTG (isopropyl-thiogalactopyranoside) for 5 h at 25°C. Cells were lysed on ice by sonication in TBS (50 mM Tris/Cl, pH 8, 0.5% Triton X-100, 150 mM NaCl) protein lysates were cleared by centrifugation (93,000 x g, 20 min, 4°C) and stored as aliquots at 80°C in TBS (50 mM Tris/Cl, pH 8, 0.5% Triton X-100, 150 mM NaCl, 10% glycerol: calmodulin binding assays) or PS buffer containing 10% glycerol (rescue experiments with vtc knockout strains).
Membrane Preparation
Total membranes were prepared from spheroplasted cells according to the protocol for preparation of vacuoles (see above), using 1 mM PMSF in the spheroplasting buffer. Flotation was carried out for 45 min, and membranes were harvested at a 8%0% ficoll interface.
Immunoprecipitation
Equal amounts of total membranes (12 mg/ml) were solubilized (15 min, 4°C) on a shaker in 50 mM Tris, pH 6.8, 100 mM NaCl, 30 mM CHAPS [3-(3-cholamidopropyl-dimethylammonio)-1-propane-sulfonate] in the presence of 0.1 mM pefabloc SC, 0.5 mM o-phenanthrolin, 0.5 µg/ml pepstatin A, and 1 mM CaCl2 or 2 mM EGTA. Solubilizates were centrifuged (20,000 x g, 10 min, 2°C, fixed angle table top centrifuge). Supernatant, 500-1000 µl, was incubated with 20 µl of protein A agarose beads (washed three times in solubilization buffer) and 20 µg of affinity-purified anti-Cmd1p antibodies for 1.5 h at 4°C on a rotator. Beads were washed twice with 500 µl of binding buffer and once with binding buffer without detergent. Proteins were eluted by heating for 10 min at 95°C in sample buffer and separated by SDS-PAGE on a 1015% gradient gel. Proteins were immunodetected after Western blot to a nitrocellulose membrane.
Binding Assay to Calmodulin Sepharose
Protein lysates (protein concentrations were 35 mg/ml, and 832 µl were used per tube for binding assay) were diluted in 800 µl of TBS buffer and incubated on a rotator with 20 µl of calmodulin Sepharose beads (washed three times in TBS buffer) in the presence of 2 mM CaCl2 or EGTA for 3 h at 4°C or for 1 h at RT. Beads were washed once with 1 ml of TBS containing 2 mM CaCl2 or EGTA. Proteins were eluted from beads by heating for 10 min at 95°C in sample buffer and separated by SDS-PAGE. Vtc3p was immunodetected after Western blot onto nitrocellulose.
Limited Proteolysis
A 2x in vitro microautophagic reaction (volume 90 µl, without luciferase) was run in the presence of 50 µM Ca2+. After incubation for 1 h at 27°C, the samples were chilled on ice, diluted with 600 µl 150 mM KCl in PS buffer, and centrifuged (6500 x g, 6 min, 2°C, fixed angle table top centrifuge). The pellet was resuspended in 500 µl of 150 mM KCl in PS buffer. Chymotrypsin was added from a 1 mg/ml stock and the sample was incubated on ice. Digestion was stopped after 10 min by adding 750 µl of chloroforme/methanol mixture (1:2). Precipitated proteins were heated for 10 min at 95°C in sample buffer and separated by SDS-PAGE on a 10% gel. Vtc3p fragments were immunodetected after Western blot to nitrocellulose. Chymotrypsin activity (0.05 mg/ml) was measured by cleaving chymotrypsin substrate I (2 mg/ml from a 5x stock). The reactions were run in a 96-well microtiter plate (total reaction volume 100 µl) in 150 mM KCl in PS buffer at RT. The cleavage of the substrate was monitored by measuring the increasing absorbance at 405 nm.
| RESULTS |
|---|
|
|
|---|
We used an in vitro system that allows to quantify microautophagic uptake activity via the uptake of soluble firefly luciferase added to purified vacuoles (Sattler and Mayer, 2000
). After the uptake reaction, the vacuoles are reisolated and protease-treated to remove residual luciferase from the vacuolar surface. Microautophagy is then quantified via the luciferase activity protected in the lumen of the vacuoles. We ran the in vitro luciferase uptake assays with vacuoles derived from deletion strains for the four Vtc genes. Vacuoles derived from all four knockout strains showed a significant reduction of microautophagic activity (Figure 1). The most severe reduction was observed for
vtc1,
vtc3, and
vtc4 vacuoles, whereas
vtc2 vacuoles showed a smaller effect. The different effects of the vtc2 and vtc3 mutations reflect the differential localization of the Vtc proteins (see below) and are due to the existence of isoforms of the VTC complex, one containing only Vtc1p/Vtc3p/Vtc4p and the other one only Vtc1p/Vtc2p/Vtc4p (H. Neumann and A. Mayer, unpublished observation).
|
|
|
|
|
-amyloid precursor (Diaz-Rodriguez et al., 2000
|
Because calmodulin was required independently of its ability to chelate Ca2+, we investigated whether the protective effect of Cmd1p on Vtc3p depended on Ca2+ binding, using yeast strains expressing calmodulins with strongly reduced Ca2+ affinities. These cmd1-5 (E31V, E67V, and E104V) and cmd1-6 (D20A, D56A, and D93A) mutants contain amino acid substitutions in each of the three calcium-binding domains of Cmd1p that remove groups coordinating Ca2+ ions (Geiser et al., 1991
). Vacuoles from such mutants showed wild-type-like (cmd1-5) or slightly increased Vtc3p levels (cmd1-6) and no signs of proteolytic sensitivity (Figure 6C). Thus, Cmd1p is important for VTC complex stability, and this function does not depend on Ca2+ binding.
We tested whether there might be a direct interaction of the VTC complex with calmodulin using purified proteins. The cytosolic parts of Vtc2p, Vtc3p, and Vtc4p consist of an N-terminal SPX domain followed by a large hydrophilic central domain. To test which part of the Vtc proteins supports binding to Cmd1p, we expressed N-terminally His6-GST-tagged versions of the Vtc domains in E. coli and incubated increasing amounts of the cleared protein lysates with Cmd1p-Sepharose. Either central cytosolic Vtc domain (Vtc2p: amino acids 183-553, Vtc3p: amino acids 183-559, and Vtc4p: amino acids 183-487) was soluble and bound to Cmd1p-Sepharose in the presence and in absence of free Ca2+. The N-terminal SPX domain of Vtc4p (amino acids 9-176) did not bind (Figure 7A). The Cmd1p-interaction of the single central Vtc domains expressed in E. coli was weakened by ophiobolin A, (Figure 7B) but not by W-7. This is in accord with the differential effects of these compounds on VTC stability. It suggests that Vtc proteins are bona fide targets for calmodulin in microautophagy, and that they can interact directly with calmodulin.
|
The EGO (exit from rapamycin-induced growth arrest) complex (composed of Ego1p, Gtr2p, and Ego3p) is needed for exit from stationary phase after rapamycin treatment and for growth in low rapamycin concentrations (Dubouloz et al., 2005
). EGO mutants also show defects in microautophagy. This poses the question whether a defect in microautophagy blocks stationary phase exit or whether microautophagic defects are rather a consequence of the block of stationary phase exit and/or the lack of EGO function. If microautophagy per se were required for stationary phase exit also other mutants with microautopagic defects should show similar phenotypes as EGO complex mutants. Therefore, we tested rapamycin-sensitive growth of VTC and EGO complex mutants.
vtc cells were spotted onto YPD plates containing 11 nM rapamycin, which is subinhibitory for growth of wild-type cells. All
vtc strains grew well on low rapamycin, whereas the EGO mutant
gtr2 did not (Figure 8A). Also in the in vitro system hypersensitivity of the EGO complex knockout strains to rapamycin could not be observed: We ran standard uptake reactions in the presence of increasing concentrations of the drug (up to 25 µM). All EGO complex mutants showed moderately reduced uptake activity (Figure 8B), which was as sensitive to increasing concentrations of rapamycin as that of wild-type vacuoles. In all of the EGO complex mutant vacuoles the content of Vtc3p was reduced in comparison to vacuoles derived from the wild-type strain, even when vacuoles were prepared in the presence of 1 mM PMSF (Figure 8C). The reduced uptake activities correlated well with this reduction in Vtc3p abundance, suggesting that there may not be a direct effect of the EGO complex on in vitro microautophagy under the conditions used.
|
| DISCUSSION |
|---|
|
|
|---|
So far, the question of the physiological relevance of microautophagy could not be definitely answered. The EGO complex is necessary for cells to exit stationary phase after rapamycin treatment (Dubouloz et al., 2005
). However, rapamycin treatment in EGO complex knockout cells comes along not only with defects in induction of microautophagy but also with a dramatic decrease of overall protein synthesis (Dubouloz et al., 2005
). In addition, recent data show that the EGO complex components have a further role in sorting of the amino acid permease Gap1p (and possibly other proteins) in response to nutrient availability (Gao and Kaiser, 2006
). These data in combination with ours suggest that the EGO complex controls multiple cellular processes. Future analyses will be necessary to dissect whether the roles of the EGO complex in microautophagy, in protein synthesis, or in protein sorting cause the defects in recovery after rapamycin treatment. In this work we present mutants (i.e., the VTC complex knockout cells) that are impaired in microautophagy but still can grow in the presence of the drug rapamycin. The microautophagic process itself may hence be dispensable for leaving the stationary and reentering the exponential growth phase. This suggests that microautophagy could be simply a means to compensate macroautophagic membrane influx after starvation and thereby regulate organellar size and lipid composition rather than being the mechanism responsible for cell recovery after exposure to rapamycin.
The interaction of calmodulin with the VTC complex suggests this complex as a bona fide target of calmodulin for micoautophagic vacuole invagination. We cannot, however, exclude that other calmodulin-binding proteins participate in the reaction. This will require identification and mutation of the calmodulin-binding site on the VTC proteins. This is not trivial because calmodulin can bind its targets in numerous different binding modes that are difficult to predict, as exemplified by the recent cocrystallization of Cmd1p with the adenylyl cyclase domain of CyaA or anthrax edema factor (Guo et al., 2005
): 49 residues of CyaA form a network of interactions with 70 residues of calmodulin. Not a single one of these 49 CyaA residues is conserved on endema factor, although both proteins interact with calmodulin via analogous "H helices," which contact the same residues on Cmd1p. Furthermore, there is growing evidence that Cmd1p can bind motifs other than
-helices. Systematic experimental analysis of the Vtc-Cmd1p complex interaction will hence be necessary. Current efforts in the lab to determine the crystal and NMR structure of the Vtc proteins bound to different ligands should be helpful in this regard.
Structural characterization may also resolve the apparent paradoxon that the calmodulin antagonist W-7 inhibits in vitro microautophagy (Uttenweiler et al., 2005
) but does not disrupt the VtcCmd1p interaction. Cmd1p might bind Vtc proteins in a conformation that is not influenced by W-7, or W-7 may alter the apo-conformation to partially resemble the Ca2+-loaded state. The latter is not unlikely because Ca2+ binding shifts calmodulin from a closed to an open conformation (Kuboniwa et al., 1995
; Zhang et al., 1995
) creating two hydrophobic pockets (Babu et al., 1985
; Kretsinger et al., 1986
), which are essential in Ca2+-dependent interactions but not for Ca2+-independent ones (Ikura et al., 1992
; Meador et al., 1992
, 1993
). W-7 binds and blocks these pockets and might, in turn, also stabilize the conformation showing the pockets, thus locking the VtcCmd1p complex in a conformation that partially resembles the Ca2+-bound state. This state is expected to be less active because the presence of Ca2+ ions retards rather than stimulates in vitro microautophagy (Uttenweiler et al., 2005
).
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
Address correspondence to: Andreas Mayer (andreas.mayer{at}unil.ch)
Abbreviations used: Cmd1, calmodulin; VTC, vacuolar transporter chaperone.
| REFERENCES |
|---|
|
|
|---|
Babu, Y. S., Sack, J. S., Greenhough, T. J., Bugg, C. E., Means, A. R., Cook, W. J. (1985). Three-dimensional structure of calmodulin. Nature 315, 3740.[CrossRef][Medline]
Bachs, O., Lanini, L., Serratosa, J., Coll, M. J., Bastos, R., Aligue, R., Rius, E., Carafoli, E. (1990). Calmodulin-binding proteins in the nuclei of quiescent and proliferatively activated rat liver cells. J. Biol. Chem 265, 1859518600.
Bergamini, E., Cavallini, G., Donati, A., Gori, Z. (2003). The anti-ageing effects of caloric restriction may involve stimulation of macroautophagy and lysosomal degradation, and can be intensified pharmacologically. Biomed. Pharmacother 57, 203208.[CrossRef][Medline]
Burgoyne, R. D. and Clague, M. J. (2003). Calcium and calmodulin in membrane fusion. Biochim. Biophys. Acta 1641, 137143.[Medline]
Cohen, A., Perzov, N., Nelson, H., Nelson, N. (1999). A novel family of yeast chaperons involved in the distribution of V-ATPase and other membrane proteins. J. Biol. Chem 274, 2688526893.
Diaz-Rodriguez, E., Esparis-Ogando, A., Montero, J. C., Yuste, L., Pandiella, A. (2000). Stimulation of cleavage of membrane proteins by calmodulin inhibitors. Biochem J 346, Pt 2359367.
Dubouloz, F., Deloche, O., Wanke, V., Cameroni, E., De Virgilio, C. (2005). The TOR and EGO protein complexes orchestrate microautophagy in yeast. Mol. Cell 19, 1526.[CrossRef][Medline]
Gao, M. and Kaiser, C. A. (2006). A conserved GTPase-containing complex is required for intracellular sorting of the general amino-acid permease in yeast. Nat. Cell Biol 8, 657667.[CrossRef][Medline]
Geiser, J. R., van Tuinen, D., Brockerhoff, S. E., Neff, M. M., Davis, T. N. (1991). Can calmodulin function without binding calcium? Cell 65, 949959.[CrossRef][Medline]
Gozuacik, D. and Kimchi, A. (2004). Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23, 28912906.[CrossRef][Medline]
Guo, Q., Shen, Y., Lee, Y. S., Gibbs, C. S., Mrksich, M., Tang, W. J. (2005). Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin. EMBO J 24, 31903201.[CrossRef][Medline]
Gutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., Deretic, V. (2004). Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753766.[CrossRef][Medline]
Harding, T. M., Hefner-Gravink, A., Thumm, M., Klionsky, D. J. (1996). Genetic and phenotypic overlap between autophagy and the cytoplasm to vacuole protein targeting pathway. J. Biol. Chem 271, 1762117624.
Harding, T. M., Morano, K. A., Scott, S. V., Klionsky, D. J. (1995). Isolation and characterization of yeast mutants in the cytoplasm to vacuole protein targeting pathway. J. Cell Biol 131, 591602.
Hohenberg, H., Mannweiler, K., Muller, M. (1994). High-pressure freezing of cell suspensions in cellulose capillary tubes. J. Microsc 175, Pt 13443.[Medline]
Hutchins, M. U., Veenhuis, M., Klionsky, D. J. (1999). Peroxisome degradation in Saccharomyces cerevisiae is dependent on machinery of macroautophagy and the Cvt pathway. J. Cell Sci 112, Pt 2240794087.[Abstract]
Ikura, M., Clore, G. M., Gronenborn, A. M., Zhu, G., Klee, C. B., Bax, A. (1992). Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science 256, 632638.
Janke, C., et al. (2004). A versatile toolbox for PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter substitution cassettes. Yeast 21, 947962.[CrossRef][Medline]
Kahn, J., Walcheck, B., Migaki, G. I., Jutila, M. A., Kishimoto, T. K. (1998). Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism. Cell 92, 809818.[CrossRef][Medline]
Kao, J. P., Alderton, J. M., Tsien, R. Y., Steinhardt, R. A. (1990). Active involvement of Ca2+ in mitotic progression of Swiss 3T3 fibroblasts. J. Cell Biol 111, 183196.
Kim, J., Dalton, V. M., Eggerton, K. P., Scott, S. V., Klionsky, D. J. (1999). Apg7p/Cvt2p is required for the cytoplasm-to-vacuole targeting, macroautophagy, and peroxisome degradation pathways. Mol. Biol. Cell 10, 13371351.
Klionsky, D. J., et al. (2003). A unified nomenclature for yeast autophagy-related genes. Dev. Cell 5, 539545.[CrossRef][Medline]
Kretsinger, R. H., Rudnick, S. E., Weissman, L. J. (1986). Crystal structure of calmodulin. J. Inorg. Biochem 28, 289302.[CrossRef][Medline]
Kubler, E., Schimmoller, F., Riezman, H. (1994). Calcium-independent calmodulin requirement for endocytosis in yeast. EMBO J 13, 55395546.[Medline]
Kuboniwa, H., Tjandra, N., Grzesiek, S., Ren, H., Klee, C. B., Bax, A. (1995). Solution structure of calcium-free calmodulin. Nat. Struct. Biol 2, 768776.[CrossRef][Medline]
Kunz, J. B., Schwarz, H., Mayer, A. (2004). Determination of four sequential stages during microautophagy in vitro. J. Biol. Chem 279, 99879996.
Leung, P. C., Graves, L. M., Tipton, C. L. (1988). Characterization of the interaction of ophiobolin A and calmodulin. Int. J. Biochem 20, 13511359.[CrossRef][Medline]
Levine, B. and Klionsky, D. J. (2004). Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6, 463477.[CrossRef][Medline]
Li, Z., Joyal, J. L., Sacks, D. B. (2001). Calmodulin enhances the stability of the estrogen receptor. J. Biol. Chem 276, 1735417360.
Longo, V. D. and Finch, C. E. (2003). Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299, 13421346.
Luan, Y., Matsuura, I., Yazawa, M., Nakamura, T., Yagi, K. (1987). Yeast calmodulin: structural and functional differences compared with vertebrate calmodulin. J. Biochem. (Tokyo) 102, 15311537.
Matsuura, I., Ishihara, K., Nakai, Y., Yazawa, M., Toda, H., Yagi, K. (1991). A site-directed mutagenesis study of yeast calmodulin. J. Biochem. (Tokyo) 109, 190197.
Meador, W. E., Means, A. R., Quiocho, F. A. (1992). Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. Science 257, 12511255.
Meador, W. E., Means, A. R., Quiocho, F. A. (1993). Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures. Science 262, 17181721.
Melendez, A., Talloczy, Z., Seaman, M., Eskelinen, E. L., Hall, D. H., Levine, B. (2003). Autophagy genes are essential for dauer development and life-span extension in C elegans. Science 301, 13871391.
Mukaiyama, H., Baba, M., Osumi, M., Aoyagi, S., Kato, N., Ohsumi, Y., Sakai, Y. (2004). Modification of a ubiquitin-like protein Paz2 conducted micropexophagy through formation of a novel membrane structure. Mol. Biol. Cell 15, 5870.
Mukaiyama, H., Oku, M., Baba, M., Samizo, T., Hammond, A. T., Glick, B. S., Kato, N., Sakai, Y. (2002). Paz2 and 13 other PAZ gene products regulate vacuolar engulfment of peroxisomes during micropexophagy. Genes Cells 7, 7590.[Abstract]
Muller, O., Bayer, M. J., Peters, C., Andersen, J. S., Mann, M., Mayer, A. (2002). The Vtc proteins in vacuole fusion: coupling NSF activity to V0 trans-complex formation. EMBO J 21, 259269.[CrossRef][Medline]
Muller, O., Neumann, H., Bayer, M. J., Mayer, A. (2003). Role of the Vtc proteins in V-ATPase stability and membrane trafficking. J. Cell Sci 116, 11071115.
Muller, O., Sattler, T., Flotenmeyer, M., Schwarz, H., Plattner, H., Mayer, A. (2000). Autophagic tubes: vacuolar invaginations involved in lateral membrane sorting and inverse vesicle budding. J. Cell Biol 151, 519528.
Murray, J. M. and Johnson, D. I. (2000). Isolation and characterization of Nrf1p, a novel negative regulator of the Cdc42p GTPase in Schizosaccharomyces pombe. Genetics 154, 155165.
Murray, J. M. and Johnson, D. I. (2001). The Cdc42p GTPase and its regulators Nrf1p and Scd1p are involved in endocytic trafficking in the fission yeast Schizosaccharomyces pombe. J. Biol. Chem 276, 30043009.
Nakagawa, I., et al. (2004). Autophagy defends cells against invading group A Streptococcus. Science 306, 10371040.
Nelson, N., Perzov, N., Cohen, A., Hagai, K., Padler, V., Nelson, H. (2000). The cellular biology of proton-motive force generation by V-ATPases. J. Exp. Biol 203, Pt 18995.[Abstract]
Nichols, B. J., Ungermann, C., Pelham, H. R., Wickner, W. T., Haas, A. (1997). Homotypic vacuolar fusion mediated by t- and v-SNAREs. Nature 387, 199202.[CrossRef][Medline]
Odorizzi, G., Babst, M., Emr, S. D. (1998). Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell 95, 847858.[CrossRef][Medline]
Ogawa, M., Yoshimori, T., Suzuki, T., Sagara, H., Mizushima, N., Sasakawa, C. (2005). Escape of intracellular Shigella from autophagy. Science 307, 727731.
Ogawa, N., DeRisi, J., Brown, P. O. (2000). New components of a system for phosphate accumulation and polyphosphate metabolism in Saccharomyces cerevisiae revealed by genomic expression analysis. Mol. Biol. Cell 11, 43094321.
Ohya, Y. and Botstein, D. (1994). Diverse essential functions revealed by complementing yeast calmodulin mutants. Science 263, 963966.
Peters, C., Bayer, M. J., Buhler, S., Andersen, J. S., Mann, M., Mayer, A. (2001). Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion. Nature 409, 581588.[CrossRef][Medline]
Peters, C. and Mayer, A. (1998). Ca2+/calmodulin signals the completion of docking and triggers a late step of vacuole fusion. Nature 396, 575580.[CrossRef][Medline]
Qu, X., et al. (2003). Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. C